Reflector Bio, a New York-based biotechnology startup developing artificial intelligence models for drug discovery, has emerged from stealth with a... Read More ...
Epigenetic reprogramming is rewriting what we thought we knew about permanent vision loss.
Immunotherapy with checkpoint inhibitors has revolutionized cancer therapy and enabled considerable therapeutic advances for ...
Lillian Chiang, Founder and CEO of Doylestown, Pennsylvania-based Evrys Bio, has received the Timothy M. Block Biotech Impact ...
("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage biotechnology company developing gene therapies designed to ...
AI maps gene switches to steer dodo revival via pigeon DNA editing Ai-pinpointed DNA switches chart a path to sculpt ...
Palisade Bio, Inc. announced clinical and translational findings presented in one oral presentation and three moderated posters at United European Gastroenterology (UEG) Week 2026, held October 17?20 ...
Five-patient Phase 1b Crohn’s disease cohort showed a 47.5% reduction in mean endoscopic disease activity and a 58.8% reduction in mean fecal ...
Pla2g2f enzyme gene preserves memory with age and resists dementia Lipid-clearing brain enzyme linked to resilient memory and ...
Harvard Researchers Identify Fat-Breaking Enzyme Gene as Key to Reversing Age-Related Memory Decline
Researchers at Harvard Medical School's Massachusetts General Hospital have published findings in Nature Neuroscience showing that the ...
A rapeseed transcription factor called BnabZIP1 boosts resistance to bacterial pathogens in Arabidopsis while paradoxically ...
Estuary Biotherapeutics, Inc., a biotechnology company developing targeted genetic medicines for serious kidney diseases, has launched with $103 million in... Read More ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results